Peter Piot
The Discovery of Ebola (1976)
Initial Encounter and Context:
- Doctor Peter Piot, currently the Director of the London School of Hygiene & Tropical Medicine (LSHTM), was in training for infectious diseases and clinical microbiology in .
- This period was exactly years after he had completed medical school.
- In September , a sample arrived at the Institute of Tropical Medicine in Antwerp, Belgium, where Piot was working.
The Physical Sample (The Blue Thermos):
- The sample was delivered in a shiny, blue thermos.
- It was brought by a pilot from a commercial flight originating in Kinshasa, the capital of modern-day Democratic Republic of Congo (then known as Zaire).
- The thermos contained two glass vials swimming in water and melting ice cubes; one of the vials was broken upon arrival.
- The accompanying information for the sample listed a suspected diagnosis of "Yellow Fever?"
- The sample consisted of blood from a Catholic missionary nun who had died of a suspected yellow fever infection.
Laboratory Analysis and Virological Methods:
- Because yellow fever is an arbovirus, the team followed standard protocols for that family of viruses.
- Diagnostic technology in did not include rapid diagnostic tests, DNA detection, or RNA detection.
- Isolation methods involved inoculating the sample into:
- Mice.
- Guinea pigs.
- Baby mice.
- Specific cell lines.
- After several days, the team observed a "cytopathic effect," meaning the cell layer was being disrupted. This indicated the presence of a toxic element or a living virus.
- Following the cell disruption, the inoculated mice began to die.
Morphological Identification:
- Since viruses cannot be seen under a normal microscope, the team used an electron microscope.
- The shape observed was unconventional and baffling: instead of the standard sphere, cube, or rectangular shapes, the virus appeared as very long filaments resembling worms.
- Lacking internet or Google, the researchers consulted a physical atlas of viruses.
- They identified only one other virus with similar morphology: the Marburg virus.
- Marburg Virus Context: This virus had previously caused an epidemic among vaccine workers in Marburg, Germany, and was known to be highly lethal.
Safety and External Confirmation:
- The initial work was performed under regular laboratory precautions (e.g., latex gloves, flow hoods), which would be considered illegal or insufficient by modern biosafety standards for such a pathogen.
- Upon hearing reports of a major hemorrhagic fever epidemic in the Zaire rainforest, the World Health Organization (WHO) ordered the laboratory to stop work immediately.
- The sample was shipped to the Centers for Disease Control (CDC) in Atlanta, Georgia.
- The team at the CDC, led by Karl Johnson, eventually proved that the virus was not Marburg, but a brand-new virus.
Field Investigation and the Naming of Ebola
The Expedition to Central Africa:
- Approximately one week after the virus was isolated, Peter Piot (then age ) traveled to Central Africa.
- He joined an international team comprising:
- Congolese public health physicians.
- American doctors from the CDC.
- Representatives from the Institut Pasteur (France).
- Specialists from South Africa.
- Piot volunteered to go to the epicenter of the epidemic, driven by the scientific excitement of discovering the transmission vector of a new pathogen.
Transmission Vectors Identified:
- The team used basic epidemiology over the course of a few days to identify two primary modes of transmission:
- Close Contact: Direct contact with someone who was sick or through funeral rites (handling the deceased).
- Contaminated Injections: The use of unsterilized needles.
- The team used basic epidemiology over the course of a few days to identify two primary modes of transmission:
The Naming Process:
- The team avoided naming the virus after the discoverers, as it was considered to be in "bad taste."
- The team avoided naming it after the epicenter village, Yambuku, to prevent stigmatizing the local population.
- They decided to follow the convention of naming viruses after rivers.
- Using a small-scale map of the region, they identified the closest river to Yambuku: the Ebola River.
- The name was chosen for its "beautiful" sound and to avoid regional stigma.
Comparison of Historical Outbreaks vs. the 2014 West African Crisis
Historical Pattern ( to ):
- There were approximately known Ebola outbreaks in this timeframe.
- Geography: Almost all were in Central Africa (Congo, South Sudan, Uganda, Gabon).
- Scale: Typically limited to to deaths per outbreak.
- Characteristics: Limited in time, place, and person; usually occurred in rural areas.
- Exceptions: The outbreak was larger, but cumulative deaths remained low.
- Cumulative statistics prior to : Approximately known deaths in total, averaging fewer than deaths per year.
The 2014 Outbreak (The "Perfect Storm"):
- Statistics: Over deaths and total cases.
- Virus Biology: Genomic analysis confirmed the virus was not significantly different, more virulent, or more lethal than previous strains. The difference was found in society and governance, not the pathogen.
- Societal Fragility: The outbreak affected Liberia, Sierra Leone, and Guinea—countries with some of the worst indicators for health, gender, development, and education.
- Historical Trauma: Liberia and Sierra Leone were recovering from decades of civil war; Guinea had a history of corrupt dictatorship.
- Healthcare Infrastructure Collapse:
- There was a massive exodus of medical professionals.
- In , Liberia had only registered physicians for a population of .
- Lack of Trust: Civil war and political history created a total lack of trust between the population and the government.
Governance and Response Failures in 2014
- Delayed Recognition: It took three months to identify the virus as Ebola because healthcare workers only "find what they are looking for," and Ebola was not expected in West Africa.
- Economic Denial: Governments were initially in denial because the region was experiencing significant economic growth ( growth rates exceeding ). There were fears that an Ebola declaration would damage trade and business.
- Response Gaps:
- The response was severely delayed.
- Until June or July of that year, Médecins Sans Frontières (MSF) was essentially the only organization actively managing the crisis.
- The World Health Organization (WHO) provided only occasional visits early on.
- Piot describes the situation as a "massive failure of governance" combined with infrastructure deficits, a lack of societal trust, and traditional beliefs.